Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ankle brace study pulled before it even started

NCT ID NCT05209347

First seen Jan 15, 2026 · Last updated Jun 21, 2026 · Updated 22 times

Summary

This study aimed to see if custom carbon fiber braces could reduce forces on the ankle joint after a fracture, potentially lowering the risk of arthritis. It planned to enroll adults with healed ankle fractures and test different brace designs. However, the study was withdrawn before any participants were enrolled, so no data was collected.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANKLE FRACTURES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Iowa

    Iowa City, Iowa, 52241, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Carbon Fiber Custom Dynamic Orthosis (CDO) - a brace

What this could lead to

If successful, this could help design braces that lower the chance of developing ankle arthritis after a fracture.

What could go wrong

The study was withdrawn before any participants enrolled, so no results are available. It is unclear if the braces actually reduce arthritis risk.

Conditions

The condition(s) this trial relates to.

Ankle Fractures arthritic joint disease osteoarthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.